3-30691909-TTATATATATA-TTATATATATATATA
Variant names:
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP6BS1BS2
The NM_003242.6(TGFBR2):c.*326_*329dupATAT variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0027 ( 1 hom., cov: 0)
Exomes 𝑓: 0.00039 ( 0 hom. )
Consequence
TGFBR2
NM_003242.6 3_prime_UTR
NM_003242.6 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.163
Publications
3 publications found
Genes affected
TGFBR2 (HGNC:11773): (transforming growth factor beta receptor 2) The protein encoded by this gene is a transmembrane protein that has a protein kinase domain, forms a heterodimeric complex with TGF-beta receptor type-1, and binds TGF-beta. This receptor/ligand complex phosphorylates proteins, which then enter the nucleus and regulate the transcription of genes related to cell proliferation, cell cycle arrest, wound healing, immunosuppression, and tumorigenesis. Mutations in this gene have been associated with Marfan Syndrome, Loeys-Deitz Aortic Aneurysm Syndrome, and the development of various types of tumors. Alternatively spliced transcript variants encoding different isoforms have been characterized. [provided by RefSeq, Aug 2017]
TGFBR2 Gene-Disease associations (from GenCC):
- familial thoracic aortic aneurysm and aortic dissectionInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Loeys-Dietz syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), PanelApp Australia, Genomics England PanelApp, G2P
- Loeys-Dietz syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -9 ACMG points.
BP6
Variant 3-30691909-T-TTATA is Benign according to our data. Variant chr3-30691909-T-TTATA is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 344669.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00272 (401/147342) while in subpopulation AFR AF = 0.00852 (340/39884). AF 95% confidence interval is 0.00778. There are 1 homozygotes in GnomAd4. There are 181 alleles in the male GnomAd4 subpopulation. Median coverage is 0. This position passed quality control check.
BS2
High AC in GnomAd4 at 401 AD gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TGFBR2 | NM_003242.6 | c.*326_*329dupATAT | 3_prime_UTR_variant | Exon 7 of 7 | ENST00000295754.10 | NP_003233.4 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TGFBR2 | ENST00000295754.10 | c.*326_*329dupATAT | 3_prime_UTR_variant | Exon 7 of 7 | 1 | NM_003242.6 | ENSP00000295754.5 |
Frequencies
GnomAD3 genomes AF: 0.00271 AC: 399AN: 147306Hom.: 1 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
399
AN:
147306
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000390 AC: 39AN: 100082Hom.: 0 Cov.: 0 AF XY: 0.000343 AC XY: 17AN XY: 49616 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
AF:
AC:
39
AN:
100082
Hom.:
Cov.:
0
AF XY:
AC XY:
17
AN XY:
49616
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
11
AN:
4054
American (AMR)
AF:
AC:
0
AN:
5244
Ashkenazi Jewish (ASJ)
AF:
AC:
1
AN:
4698
East Asian (EAS)
AF:
AC:
2
AN:
12362
South Asian (SAS)
AF:
AC:
3
AN:
6772
European-Finnish (FIN)
AF:
AC:
0
AN:
1620
Middle Eastern (MID)
AF:
AC:
2
AN:
508
European-Non Finnish (NFE)
AF:
AC:
13
AN:
57884
Other (OTH)
AF:
AC:
7
AN:
6940
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.352
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00272 AC: 401AN: 147342Hom.: 1 Cov.: 0 AF XY: 0.00252 AC XY: 181AN XY: 71732 show subpopulations
GnomAD4 genome
AF:
AC:
401
AN:
147342
Hom.:
Cov.:
0
AF XY:
AC XY:
181
AN XY:
71732
show subpopulations
African (AFR)
AF:
AC:
340
AN:
39884
American (AMR)
AF:
AC:
15
AN:
14760
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3422
East Asian (EAS)
AF:
AC:
10
AN:
5076
South Asian (SAS)
AF:
AC:
8
AN:
4692
European-Finnish (FIN)
AF:
AC:
0
AN:
9346
Middle Eastern (MID)
AF:
AC:
0
AN:
280
European-Non Finnish (NFE)
AF:
AC:
23
AN:
66958
Other (OTH)
AF:
AC:
5
AN:
2022
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.454
Heterozygous variant carriers
0
16
32
49
65
81
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Marfan syndrome Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Familial thoracic aortic aneurysm and aortic dissection Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Loeys-Dietz syndrome Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
Nov 13, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
See Variant Classification Assertion Criteria. -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.